AGM
DGX icon

Alpine Global Management’s Quest Diagnostics DGX Stock Holding History

Alpine Global Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,946
Closed -$494K – 164
2015
Q4 		$494K Sell
6,946
-1,897
-21% -$128K 0.16% 79
2015
Q3 		$544K Buy
8,843
+5,245
+146% +$367K 0.16% 51
2015
Q2 		$261K Buy
+3,598
New +$266K 0.04% 310
2015
Q1 		– Sell
-3,270
Closed -$219K – 360
2014
Q4 		$219K Buy
+3,270
New +$206K 0.04% 443

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alpine Global Management's DGX Position: Q1 2016 in Review

Alpine Global Management sold out of Quest Diagnostics (DGX) in Q1 2016, closing a stake of 6,946 shares — an estimated $494K sold.

Alpine Global Management first reported a position in DGX in Q4 2014 and held it in 4 quarters. The position peaked at $544K in Q3 2015. 557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

  • Alpine Global Management reported no remaining Quest Diagnostics position as of Q1 2016 after selling out during the quarter.
  • Alpine Global Management sold 6,946 Quest Diagnostics shares in Q1 2016, an estimated $494K.
  • Alpine Global Management first reported a position in Quest Diagnostics in Q4 2014 and held it in 4 quarters.
  • Alpine Global Management's Quest Diagnostics position peaked at $544K in Q3 2015.
  • 557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on Alpine Global Management's 13F filing for Q1 2016, filed 12 May 2016.